All these estimates are necessarily unprecise, being based on small numbers. They could be used in connection with speculations regarding the critical age at first use, arguing that a very high ratio between OR* and OR is unlikely, thus making age 18 years an appealing choice.
Finally, we do not completely agree with Dr Tomasson when he claims that the two Icelandic studies and the results of the Collaborative Group on Hormonal Factors in Breast Cancer (1996) all show that use of OC has very little impact on the risk for breast cancer. We feel that there is still a question mark concerning the effects of OC use at young age. Our study, as well as the one by the Collaborative Group give rise to some concern about this matter. The study of the Collaborative Group also found an increased risk in young users and, to quote the paper, 'The available data for use beginning before age 20 indicate that there is no substantial increase of breast cancer risk in this subgroup more than 5 years after cessation of use, but virtually all the existing information relates to women younger than 45. In the next decade women who began use as teenagers will reach their late 40s and early 50s, when breast cancer is more common. When the new data on the long-term effects of early use become available it will be necessary to re-examine the worldwide evidence'. (1936) . Despite the isolation of oestrogens and animal data implicating these substances in both initiation and promotion of mammary tumours in rodents (Eisen, 1932; Lacassagne, 1932) , evidence for a direct role in normal breast function and development of mammary neoplasia was lacking. Glascock and Hoekstra published a seminal paper in 1959 on the selective accumulation of radiolabelled synthetic oestrogens in target organs that respond to these hormones. A tritiated oestrogen derivative of high specific activity selectively localized in the mammary glands, uterus, vagina and pituitary glands of immature goats and sheep. This was important corroborative data linking oestrogen with normal breast physiology, and subsequently the selective uptake of radiolabelled systemic oestradiol by 7,12-dimethylbenzanthracene (DMBA)-induced rat mammary tumours was demonstrated (King, 1965; Mobbs, 1966; Terenius, 1968) . However, although the existence of putative oestrogen receptors was postulated they were not identified in these experiments.
The formal discovery of the oestrogen receptor (ER) came in the mid to late 1960s by groups led by Gorski and Jensen (Toft and Gorski, 1966; Jensen et al, 1968) . These workers carried out further experiments that consolidated understanding of oestrogenstimulated growth. Radiolabelled oestradiol incubated with uterine tissue of immature rats was bound to cytosolic and nuclear fractions. The oestradiol in the cytosol was associated with a specific oestrogen-binding protein that was undetectable in the nuclear fraction. These findings led to formulation of an early model for oestrogen-mediated events in which oestrogen interacted directly with target cells via cytoplasmic receptors. Subsequent translocation of the ligand-receptor complex to the nucleus was followed by interaction with DNA and modulation of gene transcription. The presence or absence of ER was consistent with data showing that uptake of tritiated oestradiol by breast tumour samples was essentially 'all or none' -tumours accumulated oestradiol either significantly or hardly at all. This preliminary model has now been refined and, in particular, evidence now suggests that native forms of the unoccupied ER do reside within the nucleus. The precise conditions that determine nuclear localization remain to be elucidated (Jensen, 1991) .
These observations have heralded the modern era of endocrine therapy in which the clinical response of advanced breast cancers could be predicted from the ER content of metastatic lesions (McGuire, 1975) and later of primary tumours (Campbell, 1981) .
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Science is an evolutionary process, and contemporary scientific debate should not eclipse nor distort historical fact. 
